California Zyloprim SJS Lawsuits: Hold Drugmakers Liable
Allopurinol (Zyloprim) has been associated with rare but severe skin reactions like Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). If you or a loved one developed SJS/TEN after taking Zyloprim, you may have legal options in California. This guide outlines potential claims, evidence to preserve, deadlines, and next steps. For a free case evaluation, contact our California team.
What Is Zyloprim and Why Lawsuits Arise
Zyloprim is the brand name for allopurinol, used to lower uric acid in conditions such as gout. The FDA-approved labeling warns of serious cutaneous reactions, including SJS/TEN, and instructs immediate discontinuation at the first sign of rash. See the FDA prescribing information.
Understanding SJS and TEN
SJS and TEN typically begin with flu-like symptoms and progress to a painful rash, blistering, and skin detachment. Complications can affect the eyes, skin, and internal organs, often requiring hospitalization. Early recognition and emergency treatment are critical.
Potential Legal Claims in California
- Failure to warn (strict liability and negligence): Manufacturers must warn of known or reasonably knowable risks. See Carlin v. Superior Court.
- Manufacturing defect (strict liability): Liability may attach if a particular lot or unit deviated from specifications and caused injury.
- Negligence: Including negligent testing, pharmacovigilance, and label maintenance.
- Warranties and misrepresentation: Breach of express/implied warranties and, where supported, fraud or negligent misrepresentation.
- Punitive damages: Available when clear and convincing evidence shows malice, oppression, or fraud. See Civil Code § 3294.
Important limitations: In California, strict-liability design-defect claims against prescription drugs are generally barred (Brown v. Superior Court), though negligence-based theories may still apply. Claims against generic manufacturers can be restricted by federal preemption for label- and design-based theories (PLIVA v. Mensing; Mutual Pharm. v. Bartlett).
Who May Be Liable
- Brand manufacturer: Primary target for warning and negligence claims. California also recognizes potential duty to users of generics in some circumstances (T.H. v. Novartis).
- Generic manufacturers and distributors: Potential defendants, but some claims may be preempted under Mensing and Bartlett.
- Healthcare providers: Separate medical negligence standards and requirements apply, including statutory limits on noneconomic damages under MICRA (Civ. Code § 3333.2).
Key Evidence to Preserve
- Medication records: Prescriptions, pharmacy labels, pill bottles, and medication guides/patient leaflets.
- Medical records: Hospital charts, dermatology/ophthalmology notes, biopsy and lab results, burn unit records, and discharge summaries.
- Timeline evidence: Photos of the rash and progression, symptom diary, work absence records.
- Communications: Patient portal messages, emails/texts with providers, and any printed instructions.
- Billing and insurance: EOBs, invoices, and receipts documenting costs.
How Causation Is Evaluated
- Temporal relationship: Interval between starting allopurinol and symptom onset.
- Differential diagnosis: Excluding other causes (e.g., infections, other medications).
- Objective findings: Biopsy, labs, and hospital records.
- Literature and safety data: Published studies and pharmacovigilance on allopurinol-associated SJS/TEN; see the FDA label.
Compensation That May Be Available
- Medical expenses and future care
- Lost income and reduced earning capacity
- Pain and suffering and loss of consortium
- Punitive damages where legally justified (Civ. Code § 3294)
Deadlines to File in California
Deadlines vary by claim type and facts. As general guidance:
- Product liability/personal injury: Often two years from injury or discovery, with exceptions (CCP § 335.1).
- Medical negligence: Different discovery and outer limits apply (CCP § 340.5).
- Claims against government entities: Strict claim presentation deadlines (Gov. Code § 911.2).
Missing a deadline can bar recovery. Speak with an attorney promptly to determine which periods apply to you.
What to Do If You Suspect SJS from Zyloprim
- Seek emergency medical care right away.
- Preserve the medication, packaging, and pharmacy paperwork.
- Document symptoms and treatment (photos, notes, and dates).
- Do not stop or change medications without medical advice unless directed in an emergency.
- Consult an attorney experienced in pharmaceutical litigation.
Practical Tips
- Ask your providers to note suspected drug causation in the chart.
- Request and save the Medication Guide you received with each fill.
- Keep a shared folder with photos, dates, and receipts to streamline your claim.
Quick Checklist
- Collect prescription labels and pill bottles
- Download hospital and specialist records
- Photograph rash progression and healing
- List all medications taken in the prior 8 weeks
- Track time off work and costs
- Schedule a legal consultation
FAQ
Do I have a case if I took a generic allopurinol?
Possibly. Some claims against generic manufacturers are preempted, but California recognizes potential innovator liability against brand manufacturers in limited circumstances. A case-specific analysis is required.
How long do I have to file?
Many product liability claims are subject to a two-year period, but discovery rules and other statutes can alter deadlines. Consult counsel promptly to preserve your rights.
What compensation can I pursue?
Medical costs, future care, lost earnings, pain and suffering, and in appropriate cases punitive damages, depending on the evidence and California law.
Will I need medical experts?
Yes. Expert testimony typically addresses causation, alternative causes, and adequacy of warnings.
Ready for next steps? Request your free consultation today.
References
- FDA: Zyloprim (allopurinol) Prescribing Information
- Brown v. Superior Court (Abbott Labs), 44 Cal.3d 1049 (1988)
- Carlin v. Superior Court, 13 Cal.4th 1104 (1996)
- T.H. v. Novartis Pharmaceuticals Corp., 4 Cal.5th 145 (2017)
- PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011)
- Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013)
- CCP § 335.1 | CCP § 340.5 | Gov. Code § 911.2 | Civ. Code § 3333.2 | Civ. Code § 3294